Despite considerable work on the epigenetic control of tumor suppressor gen
es, little is known about the potential role of promoter CpG demethylation
in the activation of oncogenes in lymphoid tumors. The HOXII proto-oncogene
is frequently activated in T-cell acute lymphoblastic leukemia (T-ALL). HO
XII activation can occur in the absence of translocation of the gene to the
T-cell receptor locus (Salvati et al., 1995), implying that activation mec
hanisms must be involved other than the juxtaposition of the gene to adjace
nt enhancing sequences. We tested whether the methylation status of the pro
ximal promoter was correlated with expression status in T-ALL and found tha
t, in all cases, expression of HOXII in T-ALL was associated with extensive
demethylation of the proximal HOXII promoter, regardless of whether or not
translocation was involved. In contrast, cells that did not express HOXII
showed a more methylated pattern of CpG residues in the proximal promoter.
Methylation of this sequence in vitro was sufficient to silence the proxima
l promoter. We propose a model in which the selection of leukemia clones vi
a a pathway involving HOXII expression requires the demethylation of its pr
omoter as a prerequisite for additional gene activation mechanisms. (C) 200
0 Wiley-Liss, Inc.